Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
lame duck special edition

A full plate for Congress before Washington turns red in January

From now until Dec. 20, Congress has a full plate of issues to deal with before Washington turns red in January. All the items on the agenda are fraught with varying levels of political risk. Let’s get into the top three we’re watching for this lame-duck special edition.

Government funding: Speaker Mike Johnson has said he wants to pass a short-term stopgap funding bill to keep the government open past the Dec. 20 deadline. Strategically, this could be a risky move for President-elect Donald Trump’s 100-day agenda.

Moving a short-term measure would ensure Congress is wrapped up in a funding debate for the first quarter of 2025, all while Johnson has a bare-bones, 218- or 219-seat majority. On top of that, assembling a three-month CR would be a heavy lift for Congress. The Pentagon hates short-term funding bills. The spending anomalies would make this a huge bill that runs thousands of pages.

Disaster relief and the farm bill: The White House sent Congress a $98.4 billion bill on Monday to help the storm-stricken Southeast. This is exactly in line with what Johnson and other congressional leaders thought the price tag would be. All four corners — Johnson, incoming Senate GOP Leader John Thune, House Minority Leader Hakeem Jeffries and Senate Majority Leader Chuck Schumer — want to get disaster relief passed. However, House Republicans will be the squeaky wheel.

The NDAA: For the last six decades, Congress has passed the annual Pentagon policy bill. The Senate is expected to move on the NDAA after Thanksgiving. House Republicans planned to put a number of bills cracking down on China in the legislation, but the chances for that are dimming.

As always, please email us with questions, comments or suggestions.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.